Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.

Author: BarohnRichard J, ChandrashekharSwathy, ClayRebecca, DimachkieMazen M, HamasakiAnai C, HerbelinLaura, JawdatOmar, McCalleyAyla, PasnoorMamatha, StatlandJeffrey

Paper Details 
Original Abstract of the Article :
Neuronal hyperexcitability (manifested by cramps) plays a pathological role in amyotrophic lateral sclerosis (ALS), and drugs affecting it may help symptomatic management and slow disease progression. We aimed to determine safety and tolerability of two doses of ranolazine in patients with ALS and e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35466411

データ提供:米国国立医学図書館(NLM)

Ranolazine: A Potential Oasis for ALS Cramps

The world of neurodegenerative diseases is full of challenges, like navigating a vast and unforgiving desert. ALS (Amyotrophic Lateral Sclerosis), a debilitating condition, can cause muscle cramps and spasms. This study delves into the potential use of ranolazine, a medication, to manage these symptoms in ALS patients. Researchers are exploring whether ranolazine, which affects neuronal excitability, could offer relief from cramps and potentially slow disease progression. This is a promising avenue, as finding an oasis in the desert of ALS symptoms could significantly improve the quality of life for patients.

Ranolazine: A Hopeful Step in the Desert of ALS

The study found that ranolazine appeared to be safe and well-tolerated in ALS patients. This is a positive finding, as it suggests that ranolazine could be a viable option for managing cramps, a common and debilitating symptom of ALS. While further research is needed to fully understand its impact on disease progression, this initial exploration shows potential for ranolazine to provide some relief in the desert of ALS.

Navigating the Desert of ALS: Seeking Relief and Understanding

The study underscores the need for continued research into new treatments for ALS, a disease that presents many challenges. The exploration of ranolazine's potential as a treatment for cramps is a valuable step in this direction. It's important to stay informed and engaged in the search for new therapies that can offer hope and support to individuals living with ALS.

Dr. Camel's Conclusion

This study demonstrates the ongoing search for effective treatments for ALS. The exploration of ranolazine as a potential therapy for cramps is a hopeful sign, offering a glimmer of light in the vast and challenging desert of ALS. Remember, just as a desert traveler needs to be resilient and resourceful, we need to continue pushing the boundaries of medical research to find solutions for those affected by this devastating disease.

Date :
  1. Date Completed 2022-06-15
  2. Date Revised 2023-07-03
Further Info :

Pubmed ID

35466411

DOI: Digital Object Identifier

NIHMS1800948

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.